Literature DB >> 27836285

Practical aspects of the two FIGO systems for management of abnormal uterine bleeding in the reproductive years.

Malcolm G Munro1.   

Abstract

The FIGO systems defining the nomenclature and symptoms of abnormal uterine bleeding (AUB) in the reproductive years (System 1) and the PALM-COEIN classification of causes of AUB (System 2) are designed to facilitate research, education, and the provision of optimum clinical care for affected women. Development of these systems has been the result of a collaborative effort of experts in bench and translational and clinical research from six continents aided by a spectrum of representatives from relevant medical societies, journals, and regulatory bodies. Integral to this development has been a decision to cease the use of poorly defined and inconsistently used terms such as menorrhagia, metrorrhagia, and dysfunctional uterine bleeding, to name a few, and replace them with a set of terms and definitions that are relatively easily understood and translated into the spectrum of languages used by medical providers and patients globally. The utilization of these systems requires a disciplined approach to obtaining a menstrual history, relatively simple laboratory investigations, and the appropriate use of imaging techniques accessible to most clinicians worldwide. This section describes the two systems, their crucial role in guiding investigation, and an approach to implementation, all designed to facilitate the creation of a menu of therapeutic options, considering the identified factors contributing to the problem of nongestational AUB.
Copyright © 2016. Published by Elsevier Ltd.

Entities:  

Keywords:  PALM-COEIN; abnormal uterine bleeding; heavy menstrual bleeding; heavy uterine bleeding; intermenstrual bleeding; menorrhagia

Mesh:

Year:  2016        PMID: 27836285     DOI: 10.1016/j.bpobgyn.2016.09.011

Source DB:  PubMed          Journal:  Best Pract Res Clin Obstet Gynaecol        ISSN: 1521-6934            Impact factor:   5.237


  8 in total

1.  Outpatient uterine assessment and treatment unit in patients with abnormal uterine bleeding: an economic modelling study.

Authors:  Alexandria Bennett; Kednapa Thavorn; Kristina Arendas; Doug Coyle; Sukhbir S Singh
Journal:  CMAJ Open       Date:  2020-12-08

2.  Racial/Ethnic Disparities/Differences in Hysterectomy Route in Women Likely Eligible for Minimally Invasive Surgery.

Authors:  Lisa M Pollack; Margaret A Olsen; Sarah J Gehlert; Su-Hsin Chang; Jerry L Lowder
Journal:  J Minim Invasive Gynecol       Date:  2019-09-10       Impact factor: 4.137

3.  Effects of total laparoscopic hysterectomy on the clinical outcomes of patients with uterine fibroids.

Authors:  Lang Zheng; Dan Liu; Chunyan Hu
Journal:  Am J Transl Res       Date:  2022-04-15       Impact factor: 3.940

4.  Hysteroscopic and aspiration biopsies in the histologic evaluation of the endometrium, a comparative study.

Authors:  Gilberto Massaki Utida; Jaime Kulak
Journal:  Medicine (Baltimore)       Date:  2019-10       Impact factor: 1.889

5.  The COVID-19 pandemic and the menstrual cycle: research gaps and opportunities.

Authors:  Gemma C Sharp; Abigail Fraser; Gemma Sawyer; Gabriella Kountourides; Kayleigh E Easey; Gemma Ford; Zuzanna Olszewska; Laura D Howe; Deborah A Lawlor; Alexandra Alvergne; Jacqueline A Maybin
Journal:  Int J Epidemiol       Date:  2022-06-13       Impact factor: 9.685

6.  Barriers to seeking consultation for abnormal uterine bleeding: systematic review of qualitative research.

Authors:  Claire Henry; Alec Ekeroma; Sara Filoche
Journal:  BMC Womens Health       Date:  2020-06-12       Impact factor: 2.809

7.  Prevalence and knowledge of heavy menstrual bleeding among gynecology outpatients by scanning a WeChat QR Code.

Authors:  Sisi Su; Xin Yang; Qing Su; Yang Zhao
Journal:  PLoS One       Date:  2020-04-02       Impact factor: 3.240

8.  Beyond the numbers-understanding women's experiences of accessing care for abnormal uterine bleeding (AUB): a qualitative study.

Authors:  Claire Henry; Regina Jefferies; Alec Ekeroma; Sara Filoche
Journal:  BMJ Open       Date:  2020-11-17       Impact factor: 2.692

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.